CLINICAL_TRIALS ClinicalTrials.gov record update

Immunogenicity & Safety Study of GSK Biologicals' Meningococcal Vaccine GSK134612 When Co-Administered With GSK Biologicals' MMRV Vaccine (Priorix-Tetra™) in Healthy 12 to 23-Month-Old Children

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00474266
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:30.659028+00:00
Published At: 2017-12-15T00:00:00+00:00
Record Updated At: 2019-11-18
Results Posted At: 2017-12-15
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Infections, Meningococcal"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2019-11-18"
protocolSection.identificationModule.nctId: "NCT00474266"
protocolSection.identificationModule.officialTitle: "Immunogenicity \u0026 Safety Study of GSK Biologicals\u0027 Meningococcal Vaccine GSK134612 When Co-Administered With GSK Biologicals\u0027 MMRV Vaccine (Priorix-Tetra\u2122) in Healthy 12 to 23-Month-Old Children"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2017-12-15"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.